PHIO PHARMACEUTICALS CORP. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- PHIO PHARMACEUTICALS CORP. stock issued during period, value, new issues for the quarter ending 2025-03-31 was $6.49M.
- PHIO PHARMACEUTICALS CORP. stock issued during period, value, new issues for the quarter ending 2024-09-30 was $2.65M.
- PHIO PHARMACEUTICALS CORP. stock issued during period, value, new issues for the quarter ending 2023-06-30 was $5.05M.
- PHIO PHARMACEUTICALS CORP. stock issued during period, value, new issues for the quarter ending 2021-03-31 was $6.91M, a 370.89% increase year-over-year.
- PHIO PHARMACEUTICALS CORP. stock issued during period, value, new issues for fiscal 2024 was $4.00M, a 46.30% decline from fiscal 2023.
- PHIO PHARMACEUTICALS CORP. stock issued during period, value, new issues for fiscal 2023 was $7.45M.
- PHIO PHARMACEUTICALS CORP. stock issued during period, value, new issues for fiscal 2021 was $6.91M, a 38.33% increase from fiscal 2020.
- PHIO PHARMACEUTICALS CORP. stock issued during period, value, new issues for fiscal 2020 was $4.99M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2025-03-31 | $6.49M 10-Q · filed 2025-08-14 | |
| 2024-12-31 | $4.00M 10-K · filed 2025-03-31 | |
| 2024-09-30 | $2.65M 10-Q · filed 2024-11-14 | |
| 2023-12-31 | $7.45M 10-K · filed 2025-03-31 | |
| 2023-06-30 | $5.05M 10-Q · filed 2024-11-14 | |
| 2021-12-31 | $6.91M 10-K · filed 2023-03-22 | |
| 2021-03-31 | $6.91M 10-Q · filed 2022-11-10 | |
| 2020-12-31 | $4.99M 10-K · filed 2021-03-25 | |
| 2020-06-30 | $3.53M 10-Q · filed 2020-11-10 | |
| 2020-03-31 | $1.47M 10-Q · filed 2020-11-10 | |
| 2019-12-31 | -$58.00K 10-K · filed 2020-03-26 | |
| 2019-09-30 | -$52.00K 10-Q · filed 2019-11-12 | |
| 2018-12-31 | $1.31M 10-K · filed 2020-03-26 | |
| 2018-09-30 | $21.00K 10-Q · filed 2019-11-12 | |
| 2018-06-30 | $359.00K 10-Q · filed 2019-11-12 | |
| 2018-03-31 | $932.00K 10-Q · filed 2019-11-12 | |
| 2017-12-31 | $290.00K 10-K · filed 2019-03-27 | |
| 2016-12-31 | $152.00K 10-K · filed 2018-03-26 | |
| 2015-12-31 | $64.00K 10-K · filed 2017-03-30 | |
| 2014-12-31 | $1.89M 10-K · filed 2016-03-30 | |
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-30 | $15.65M 10-K · filed 2015-03-30 |
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | $15.65M derived: sum of 4 quarters · filed 2013-11-14 |
| 2013-06-30 | $4.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14 | |
| 2013-03-31 | $15.65M 10-Q · filed 2013-05-15 | |
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-29 | $6.17M 10-K · filed 2013-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |